Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Contraceptive coverage grows, but significant challenges remain.

Gail Hayden

    Managed Care Interface
    |February 3, 2005
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Postmortem procedures. Services for the deceased need the same respect as when the person was alive.

    Contemporary longterm care·2003
    Same author

    Accommodating the disabled. Know your obligations and options for residents with special needs.

    Contemporary longterm care·2002
    See all related articles

    Most health insurance plans cover women's health care and contraception. However, not all Food and Drug Administration-approved methods are reimbursed, and some employers opt out despite legal mandates for equal coverage.

    Area of Science:

    • Healthcare Policy
    • Women's Health
    • Reproductive Health

    Background:

    • Most health insurance plans cover general women's healthcare services.
    • Contraception is a key component of women's reproductive healthcare.
    • Existing policies aim for equitable coverage but face implementation challenges.

    Purpose of the Study:

    • To examine the extent of health insurance coverage for women's healthcare, specifically contraception.
    • To identify disparities in reimbursement for Food and Drug Administration-approved contraceptive methods.
    • To assess the impact of employer opt-out provisions on access to contraception.

    Main Methods:

    • Analysis of state mandates for equal coverage between men and women.
    • Review of insurance plan documents and employer policies.

    Related Experiment Videos

  • Examination of reimbursement data for various contraceptive methods.

    • Main Results:

    • While 21 states mandate equal coverage, not all FDA-approved contraceptive methods receive full reimbursement.
    • Employer opt-out provisions continue to limit access to certain women's health services, including contraception.
    • Discrepancies exist in coverage despite legal frameworks promoting parity.

    Conclusions:

    • Despite legal mandates, comprehensive insurance coverage for all FDA-approved contraception is not universal.
    • Employer exemptions and inconsistent reimbursement policies create barriers to accessing essential reproductive healthcare.
    • Further policy interventions are needed to ensure equitable and complete contraceptive coverage for all women.